Milestone Pharmaceuticals (MIST) Price to Book (2019 - 2026)

Milestone Pharmaceuticals (MIST) has reported Price to Book for 8 consecutive years, with 9.16 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 256.58% year-over-year to 9.16; the trailing twelve-month figure through Jun 2026 stood at 9.16 (up 256.58% YoY), and the FY2025 full-year result was 4.06, down 57.64% from the prior year.
• Price to Book advanced to 9.16 in Q2 2026 per MIST's latest filing, from 3.89 in the prior quarter.
• Across five years, Price to Book topped out at 9.58 in Q4 2024 and bottomed at 6.99 in Q1 2025.
• Historically, Price to Book has averaged 3.22 across 5 years, with a median of 3.25 in 2023.
• The sharpest annual moves came in 2025 and 2026: Price to Book sank 392.63% in 2025, then jumped 256.58% in 2026.
• Over 5 years, Price to Book stood at 2.05 in 2022, then jumped by 109.02% to 4.28 in 2023, then surged by 123.91% to 9.58 in 2024, then sank by 57.64% to 4.06 in 2025, then soared by 125.73% to 9.16 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 9.16, 3.89, and 4.06 for Q2 2026, Q1 2026, and Q4 2025 respectively.